JPMorgan International Research Enhanced Equity ETF (JIRE)
| Assets | $5.12B |
| NAV | $47.89 |
| Expense Ratio | 0.24% |
| PE Ratio | n/a |
| Shares Out | 106.98M |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| 1-Year Return | +1.45% |
| Volume | 250,118 |
| Open | 49.19 |
| Previous Close | 48.08 |
| Day's Range | 49.10 - 49.60 |
| 52-Week Low | 47.39 |
| 52-Week High | 49.60 |
| Beta | n/a |
| Holdings | 224 |
| Inception Date | Jun 10, 2022 |
About JIRE
Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It seeks to outperform the MSCI EAFE Index over time while maintaining similar risk characteristics, including sector and geographic risks. In implementing its strategy, the fund primarily invests in securities included within the universe of the index. In addition, it may also invest in securities not included within the index. The fund only invests in the securities of companies located in developed markets.
Top 10 Holdings
19.25% of assets| Name | Symbol | Weight |
|---|---|---|
| NESTLE SA COMMON STOCK | n/a | 2.86% |
| ROCHE HOLDING AG COMMON | n/a | 2.38% |
| NOVO NORDISK A/S COMMON | n/a | 2.06% |
| ASML Holding | ASML | 1.98% |
| CASH OR CASH COLLATERAL | n/a | 1.89% |
| LVMH MOET HENNESSY LOUIS | n/a | 1.86% |
| AstraZeneca | AZN | 1.70% |
| NOVARTIS AG COMMON STOCK | n/a | 1.68% |
| TOTALENERGIES SE COMMON | n/a | 1.46% |
| DIAGEO PLC COMMON STOCK | n/a | 1.38% |
News
J.P. Morgan Asset Management Completes Conversion of Four Mutual Funds to ETFs
Listing of JPMorgan International Research Enhanced Equity ETF (JIRE) brings firm's fast-growing active ETF complex to 22 active strategies NEW YORK , June 14, 2022 /PRNewswire/ -- J.P. Morgan Asset Man...
JPMorgan Converts International Research Enhanced Equity Fund Into JIRE ETF
JPMorgan Asset Management converted its JPMorgan International Research Enhanced Equity Fund into the JPMorgan International Research Enhanced Equity ETF (NYSE Arca: JIRE). The fund invests primarily in...